(Q30420964)

21 June 2017

title

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis (English)

1 reference

21 June 2017

0 references

1 reference

Ana C Ribeiro

1

1 reference

21 June 2017

Ieda M Laurindo

2

1 reference

21 June 2017

Lissiane K Guedes

3

1 reference

21 June 2017

Carla G Saad

4

1 reference

21 June 2017

Julio C Moraes

5

1 reference

21 June 2017

Clóvis A Silva

6

1 reference

21 June 2017

Eloisa Bonfa

7

1 reference

21 June 2017

language of work or name

1 reference

1 March 2013

1 reference

Arthritis Care and Research

21 June 2017

published in

1 reference

21 June 2017

volume

65

1 reference

21 June 2017

issue

3

1 reference

21 June 2017

page(s)

476-480

1 reference

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

21 June 2017

cites work

1 reference

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.

21 January 2018

1 reference

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

21 January 2018

1 reference

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study

21 January 2018

1 reference

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study

21 January 2018

1 reference

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases

21 January 2018

1 reference

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae.

21 January 2018

1 reference

Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo

21 January 2018

1 reference

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

21 January 2018

1 reference

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects

21 January 2018

1 reference

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.21838

1 reference

21 June 2017

1 reference